Evidence map›Paper›PMID 41741582›Full record

ArticleScientific reports2026

Enhanced crystallinity, hardness and thermal stability of PEEK/TC4 composites for biomedical applications.

Bakytzhan Sariyev, HJeevan Rao, Assylbek Ozhiken, Kassymbek Ozhikenov

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bakytzhan SariyevReLive Research, Astana, 010000, Kazakhstan. b.sariyev@reliveres.com.
HJeevan RaoReLive Research, Astana, 010000, Kazakhstan.
Assylbek OzhikenInstitute of Automation and Information Technologies, Satbayev University, Almaty, 050000, Kazakhstan.
Kassymbek OzhikenovInstitute of Automation and Information Technologies, Satbayev University, Almaty, 050000, Kazakhstan.

Funding

Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan BR24992820
6 · The paper itself

Abstract

Polyether-ether-ketone (PEEK) is widely recognized as a high-performance polymer for biomedical and structural applications, yet its limited hardness and moderate thermal resistance often restrict its use under demanding service conditions. This study presents the development of PEEK/Ti-6Al-4 V (TC4) composites processed via centrifugal powder compaction followed by vacuum sintering. Three compositions PT(20), PT(30), and PT(40), containing 20%, 30%, and 40% TC4 by weight were systematically investigated. Scanning electron microscopy (SEM) revealed homogeneous dispersion of TC4 particles in the PEEK matrix with localized interfacial bonding, as required for ensuring mechanical integrity during cyclic stressing conditions. Differential scanning calorimetry (DSC) showed that TC4 particles function as heterogeneous nucleating agents, which result in the enhancement of crystallinity from 41% in neat PEEK to 48% in the PT(40) composite, without significantly affecting the melting temperature. Moreover, X-ray Diffraction (XRD) supports DSC results in that metal fillers enhance the crystallization of polymer matrix. Thermogravimetric analysis (TGA) demonstrated improved thermal stability, with PT(40) composite retaining 75% weight at 800 °C compared to 53% of neat PEEK, which indicates suitability in temperature changing environments. Microhardness measurements indicated rising values with TC4 content, reaching a 35% improvement in PT(40). These findings demonstrate that the applied processing method enables property-tailored PEEK/TC4 composites suitable for thermally stable, mechanically robust structures demonstrating potential for demanding structural or biomedical applications.

Indexed as

BiomaterialsCrystallinityMicrohardnessPEEKPowder metallurgyTC4

Identifiers

PMID41741582
PMCPMC13046962

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.